↓ Skip to main content

Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study

Overview of attention for article published in BMJ Medicine, February 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 142)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
41 news outlets
blogs
4 blogs
policy
1 policy source
twitter
8107 X users
facebook
1 Facebook page
reddit
7 Redditors
video
2 YouTube creators

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
Published in
BMJ Medicine, February 2023
DOI 10.1136/bmjmed-2022-000373
Pubmed ID
Authors

Anders Husby, Hanne Løvdal Gulseth, Petteri Hovi, Jørgen Vinsløv Hansen, Nicklas Pihlström, Nina Gunnes, Tommi Härkänen, Jesper Dahl, Øystein Karlstad, Tiina Heliö, Lars Køber, Rickard Ljung, Anders Hviid

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 8,107 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 20%
Other 5 17%
Student > Ph. D. Student 4 13%
Student > Bachelor 3 10%
Student > Master 2 7%
Other 2 7%
Unknown 8 27%
Readers by discipline Count As %
Medicine and Dentistry 14 47%
Arts and Humanities 2 7%
Immunology and Microbiology 2 7%
Chemical Engineering 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 0 0%
Unknown 10 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4844. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2024.
All research outputs
#882
of 26,744,825 outputs
Outputs from BMJ Medicine
#1
of 142 outputs
Outputs of similar age
#20
of 494,011 outputs
Outputs of similar age from BMJ Medicine
#1
of 16 outputs
Altmetric has tracked 26,744,825 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 142 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 141.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 494,011 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.